PQA is committed to patient-centered principles, including health equity, in our work to improve medication safety, adherence and appropriate use.

Welcome to Five For Friday. We are less two weeks away from the 2021 PQA Annual Meeting, May 11-13. Today, April 30, is the last day to receive the discount registration rate.

PQA is investigating the barriers and facilitators of prescription turnaround time in the specialty pharmacy setting.

Welcome to the fourth edition of Five For Friday. We are less than one month away from the 2021 PQA Annual Meeting, May 11-13.

PQA’s education programs are designed to expand knowledge and develop medication use quality skills. Our Medication Use Quality CE program, our Annual Meeting and the monthly Quality Forum Webinar series are just three of the ways we showcase best practices and novel approaches to improving medication safety, adherence and appropriate use.

Welcome to the third edition of Five For Friday. As I reflect on my first two months as your CEO, I am pleased to share that my two primary assumptions about PQA have proven to be true. 

PQA’s Board of Directors represents a diverse group of thought leaders and experts in healthcare, who understand how medication optimization improves patient outcomes and supports a value-based care system. Their expertise helps PQA advance the safe and appropriate use of medicines. This blog is one in a series profiling PQA's Board members. 

PQA is a non-profit organization with 250 diverse members across healthcare. Our members include community and specialty pharmacy organizations, pharmacists and other healthcare providers, pharmacies, health plans, pharmacy benefit managers, life sciences, technology vendors, government agencies, health information technology partners, researchers, accrediting organizations and academia.

The nation’s leading health care organizations come together through PQA to improve medication access, adherence, safety and appropriate use. Our work is essential for high-quality, value-based care. 

It’s my pleasure to personally invite you to join us at the 2021 PQA Annual Meeting, which will take place online, May 11-13. While we are all looking forward to the time when we can meet together face-to-face, we are excited to continue to host this important meeting virtually and provide you with high-quality educational programs and events which meet your needs.

PQA endorsed two new diabetes-focused health plan performance measures in December 2020. More than 34 million Americans have diabetes, according to the Centers for Disease Control and Prevention. These measures will help evaluate the quality of care for a disease that annually costs America $327 billion.

The nation’s leading health care organizations come together through PQA to improve medication access, adherence, safety and appropriate use. Our work is essential for high-quality, value-based care. 

The PQA Quality Forum Webinar is a regular, recurring series on healthcare quality topics with a focus on medication use and medication services. It is a forum for educating and engaging with PQA members and quality-focused healthcare professionals.

PQA’s January 21, 2021, Quality Forum welcomed a panel of experts to discuss best practices to support tapering patients on long-term opioid therapy (LOT) for chronic non-cancer pain (CNCP) in out-patient settings. While the presenters noted more research is needed on the long-term benefits and side effects of opioid tapering, the results thus far have been promising.

Aisha Salman, MPH, a Program Officer at the National Academy of Medicine (NAM), began the conversation with an overview of the organization’s Action Collaborative on Countering the U.S. Opioid Epidemic.

Salman noted the severity of the opioid crisis in the U.S. Over 130 Americans die from an overdose every day, and 2.1 million people suffer from opioid use disorder. The opioid crisis cost $2.5 trillion between 2015 and 2018, and costs have been rapidly rising due to COVID-19.

In response, the NAM Action Collaborative seeks to apply a portfolio approach to address the epidemic, recognizing that no single policy will be enough. Established in 2018, the Action Collaborative is a public-private partnership with more than 60 participating members. The goal is facilitating a cohesive, systems response to the opioid crisis.

“We accomplish more when we work together,” Salman said. “It illustrates the necessity for a systems response to address a public health crisis like the opioid epidemic and underscores the important role that the Action Collaborative plays within this ecosystem.”

The Action Collaborative has four focus areas, each with a designated working group:

As we celebrate Black History Month, I am reminded of one experience that had a profound impact on my view of health access and the pharmacist’s role in addressing medication use quality through team-based care.

Micah Cost, PharmD, MS, is PQA's CEO. Today begins his third week leading the organization. This blog features the message he shared with PQA members on February 1, his first day in charge. Follow Cost and PQA on Twitter for more insights on the organization's daily work to improve medication use quality.

The PQA Quality Forum Webinar is a regular, recurring series on healthcare quality topics with a focus on medication use and medication services. It is a forum for educating and engaging with PQA members and quality-focused healthcare professionals.

As today marks my final day at PQA in the role of CEO, I have taken some time to reflect on the past 15 years, and the opportunity that was presented to me in 2006 to build and lead a multi-stakeholder organization, the Pharmacy Quality Alliance. We set out to build a sustainable model for advancing the safe and appropriate use of medications through the development of meaningful and actionable quality measures that all stakeholders would have an opportunity to shape through a consensus-based process.

PQA’s Strategic Plan for 2021 is focused on three, timely initiatives for medication use quality: the social determinants of health, innovative pathways for measure development, and immunization services.